---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-26-002168"
form_type: "8-K"
ticker: "PAYS"
cik: "0001496443"
company_name: "Paysign, Inc."
filed_at: "2026-03-24T23:59:59+00:00"
generated_at: "2026-05-15T09:11:50.812911+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Paysign FY2025 revenue $82.0M (+40.5%); guides FY2026 revenue $106.5-110.5M, net income nearly doubles

## Summary
- Full-year 2025 total revenues $82.0M (up 40.5% YoY); net income $7.55M ($0.13 diluted EPS) vs $3.82M ($0.07) in 2024.
- Adjusted EBITDA $19.94M (up 107.3% YoY); pharma revenue +167.8% to $33.89M on 55 new patient affordability programs.
- Added 115 net plasma centers (595 total); plasma revenue +4.0% to $45.62M.
- Gamma acquisition (BECS under FDA review) closed March 2025; exited with $21.07M cash, zero debt.
- FY2026 guidance: revenue $106.5-110.5M (30-35% growth), net income $13-16M ($0.21-0.26 EPS), adjusted EBITDA $30-33M.

## SEC filing metadata
- accession: 0001683168-26-002168
- form_type: 8-K
- ticker: PAYS
- cik: 0001496443
- company_name: Paysign, Inc.
- filed_at: 2026-03-24T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1496443/000168316826002168/0001683168-26-002168-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1496443/000168316826002168/paysign_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-26-002168
- JSON: https://secwatch.observer/filing/0001683168-26-002168.json
- Plain text: https://secwatch.observer/filing/0001683168-26-002168.txt

## Key facts
- Earnings Releases
  Paysign, Inc. reported fourth quarter 2025 results: revenue total revenues of $22.76 million, net income net income of $1.36 million, EPS $0.02 per diluted share.
  - Period: fourth quarter 2025
  - Revenue: total revenues of $22.76 million
  - Net income: net income of $1.36 million
  - EPS: $0.02 per diluted share
  - Result: reported results
  source text: Fourth quarter 2025 total revenues of $22.76 million, up 45.8% from fourth quarter 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/1496443/000168316826002168/0001683168-26-002168-index.htm
- Earnings Releases
  Paysign, Inc. reported full-year 2025 results: net income net income of $7.55 million.
  - Period: full-year 2025
  - Net income: net income of $7.55 million
  - Result: reported results
  source text: Full-year 2025 total revenues of $82.0 million, up 40.5% from 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/1496443/000168316826002168/0001683168-26-002168-index.htm
- Earnings Releases
  Paysign, Inc. reported full-year 2025 results: net income net income of $7.55 million.
  - Period: full-year 2025
  - Net income: net income of $7.55 million
  - Result: reported results
  source text: Total revenues increased 40.5%, or $23.64 million to $82.02 million from $58.38 million in 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1496443/000168316826002168/0001683168-26-002168-index.htm
- Earnings Releases
  Paysign, Inc. reported full-year 2025 results: net income net income of $7.55 million.
  - Period: full-year 2025
  - Net income: net income of $7.55 million
  - Result: reported results
  source text: Full-year 2025 net income of $7.55 million, or $0.13 per diluted share, versus net income of $3.82 million, or $0.07 per diluted share for full-year 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/1496443/000168316826002168/0001683168-26-002168-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.